zoliflodacin 3 GM Granules for Oral Suspension
- RxCUI
- 2739783
- RxNorm name
- zoliflodacin 3 GM Granules for Oral Suspension
- Display name
- zoliflodacin 3 GM Granules for Oral Suspension
- Full name
- zoliflodacin 3 GM Granules for Oral Suspension
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:57
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| NUZOLVENCE | ZOLIFLODACIN | La Jolla Pharmaceutical Company | 4beda35a-21b0-4b34-84ea-be6ea8cae50f | 2025-12-22 | Warnings, Adverse reactions | 2739783 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4beda35a-21b0-4b34-84ea-be6ea8cae50f | zoliflodacin 3 GM Granules for Oral Suspension [PSN] · zoliflodacin 3000 MG Granules for Oral Suspension [SCD] · zoliflodacin 3 GM Granules for Oral Suspension [SY] | 3 | 3 | These highlights do not include all the information needed to use NUZOLVENCE safely and effectively. See full prescribing information for NUZOLVENCE. NUZOLVENCE ® (zoliflodacin) for oral suspension Initial U.S. Approval: 2025 | 20251222 |
| 19e212d6-3861-f40e-afb3-1904eb5bc35b | zoliflodacin 3 GM Granules for Oral Suspension [PSN] · zoliflodacin 3000 MG Granules for Oral Suspension [SCD] · zoliflodacin 3 GM Granules for Oral Suspension [SY] | 3 | 1 | BULK INGREDIENT TEMPLATE | 20260129 |